Literature DB >> 29960693

Cognitive-Behavioral Therapy for Children With Anxiety and Comorbid Attention-Deficit/Hyperactivity Disorder.

Karen L Gould1, Melanie Porter1, Heidi J Lyneham1, Jennifer L Hudson2.   

Abstract

OBJECTIVE: To determine whether comorbid attention-deficit/hyperactivity disorder (ADHD) diagnosis (including subtype) predicts response to cognitive-behavior therapy (CBT) for anxiety in children and to examine change in ADHD symptoms after treatment of primary anxiety.
METHOD: A sample of 842 children 5 to 18 years of age received CBT for a primary anxiety disorder. A subsample of 94 children met criteria for comorbid mild-to-moderate ADHD, mostly consisting of predominantly inattentive (n = 61) and combined (n = 27) subtypes. Outcome was defined as response (change in diagnostic severity) and remission (absence of the primary diagnosis) at each time point (after treatment and 3- and/or 6-month follow-up) and analyzed using linear and logistic mixed models.
RESULTS: Neither ADHD diagnosis nor subtype predicted response or remission rates for children's primary anxiety disorders. Children with ADHD also showed modest yet significant improvements in ADHD symptoms after CBT for anxiety.
CONCLUSION: The present findings support the suitability of manual-based group-based CBT for anxiety treatment in children with nonprimary ADHD. Further research should examine whether the positive outcomes reported can be extended to children with primary or severe ADHD.
Copyright © 2018 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; anxiety; mental disorders; psychology; therapy

Mesh:

Year:  2018        PMID: 29960693     DOI: 10.1016/j.jaac.2018.03.021

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  4 in total

1.  Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial.

Authors:  Emma Sciberras; Daryl Efron; Pooja Patel; Melissa Mulraney; Katherine J Lee; Cathy Mihalopoulos; Lidia Engel; Ronald M Rapee; Vicki Anderson; Jan M Nicholson; Rachel Schembri; Harriet Hiscock
Journal:  BMC Psychiatry       Date:  2019-11-13       Impact factor: 3.630

Review 2.  The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review.

Authors:  Di Fu; Dan-Dan Wu; Hong-Li Guo; Ya-Hui Hu; Ying Xia; Xing Ji; Wei-Rong Fang; Yun-Man Li; Jing Xu; Feng Chen; Qian-Qi Liu
Journal:  Front Psychiatry       Date:  2022-02-09       Impact factor: 4.157

3.  Associations Between Anxiety and Home Learning Difficulties in Children and Adolescents with ADHD During the COVID-19 Pandemic.

Authors:  Anna Jackson; Glenn A Melvin; Melissa Mulraney; Stephen P Becker; Mark A Bellgrove; Jon Quach; Delyse Hutchinson; Elizabeth M Westrupp; Alicia Montgomery; Emma Sciberras
Journal:  Child Psychiatry Hum Dev       Date:  2022-03-15

4.  Developmental Relations Between Internalising Problems and ADHD in Childhood: a Symptom Level Perspective.

Authors:  Lydia Gabriela Speyer; Manuel Eisner; Denis Ribeaud; Michelle Luciano; Bonnie Auyeung; Aja Louise Murray
Journal:  Res Child Adolesc Psychopathol       Date:  2021-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.